Log In
Print
BCIQ
Print
Print this Print this
 

Invega Sustenna, Xeplion (paliperidone palmitate)

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionOnce-monthly intramuscular injection of paliperidone, a metabolite of risperidone
Molecular Target Monoamine receptors
Mechanism of ActionMonoaminergic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today